Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

ClinicalTrials.gov ID: NCT05251259

Public ClinicalTrials.gov record NCT05251259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Atuliflapon Given Orally Once Daily for Twelve Weeks in Adults With Moderate to Severe Uncontrolled Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomised, placebo-controlled, double-blind study to assess the efficacy and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma.

Study identification

NCT ID
NCT05251259
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
670 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 27, 2022 (Actual)
Primary completion
Jan 7, 2026 (Actual)
Completion
Jan 7, 2026 (Actual)
Last update posted
Jan 14, 2026

2022 – 2026

United States locations

U.S. sites
64
U.S. states
22
U.S. cities
55
Facility City State ZIP Site status
Research Site Birmingham Alabama 35211 —
Research Site Sheffield Alabama 35660 —
Research Site Phoenix Arizona 85020 —
Research Site Tucson Arizona 85741 —
Research Site Little Rock Arkansas 72212 —
Research Site Bakersfield California 93301 —
Research Site Fountain Valley California 92708 —
Research Site Huntington Beach California 92647 —
Research Site Los Angeles California 90025 —
Research Site Newport Beach California 92663 —
Research Site San Jose California 95117 —
Research Site Valencia California 91355 —
Research Site Colorado Springs Colorado 80907 —
Research Site Cutler Bay Florida 33157 —
Research Site Cutler Bay Florida 33189 —
Research Site Hialeah Florida 33012 —
Research Site Hialeah Florida 33015 —
Research Site Hialeah Florida 33016 —
Research Site Miami Florida 33125 —
Research Site Miami Florida 33155 —
Research Site Miami Florida 33173 —
Research Site Miami Florida 33174 —
Research Site Orlando Florida 32807 —
Research Site Tampa Florida 33613 —
Research Site Tampa Florida 33615 —
Research Site Fayetteville Georgia 30214 —
Research Site Lithonia Georgia 30038 —
Research Site Savannah Georgia 31406 —
Research Site Boise Idaho 83706 —
Research Site Lexington Kentucky 40509 —
Research Site Owensboro Kentucky 42301 —
Research Site Oxon Hill Maryland 20745 —
Research Site New Bedford Massachusetts 02740 —
Research Site Ann Arbor Michigan 48105 —
Research Site Farmington Hills Michigan 48336 —
Research Site Saint Charles Missouri 63301 —
Research Site St Louis Missouri 63141 —
Research Site East Orange New Jersey 07018 —
Research Site Toms River New Jersey 08755 —
Research Site The Bronx New York 10459 —
Research Site Valhalla New York 10595 —
Research Site Charlotte North Carolina 28210 —
Research Site Charlotte North Carolina 28287 —
Research Site Gastonia North Carolina 28054 —
Research Site Wilmington North Carolina 28401 —
Research Site Blue Ash Ohio 45242 —
Research Site Dayton Ohio 45439 —
Research Site Edmond Oklahoma 73034 —
Research Site Pittsburgh Pennsylvania 15241 —
Research Site Columbia South Carolina 29204 —
Research Site Greenville South Carolina 29615 —
Research Site Spartanburg South Carolina 29303 —
Research Site Austin Texas 78705 —
Research Site Beaumont Texas 77701 —
Research Site Bellaire Texas 77401 —
Research Site Dallas Texas 75225 —
Research Site El Paso Texas 79902 —
Research Site El Paso Texas 79903 —
Research Site Houston Texas 77022 —
Research Site McKinney Texas 75069 —
Research Site San Antonio Texas 78258 —
Research Site Sugar Land Texas 77479 —
Research Site Tomball Texas 77375 —
Research Site Milwaukee Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 170 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05251259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05251259 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →